Figures & data
Figure 1. Primary microglia purity was identified by immunofluorescence. Blue signal indicates nuclear staining with DAPI; red signal represents CD11b staining with CY3; arrows represent microglia with typical morphology.
![Figure 1. Primary microglia purity was identified by immunofluorescence. Blue signal indicates nuclear staining with DAPI; red signal represents CD11b staining with CY3; arrows represent microglia with typical morphology.](/cms/asset/e669c2cb-5d88-47ff-8ef0-92ec0868ba3f/iphb_a_1991959_f0001_c.jpg)
Figure 2. Transduction rate of lentiviral plasmid in microglia. Neonatal rat microglia were plated in six-well plates with complete medium 24 h prior infection. Next day, microglia were infected with IRE1 overexpressed lentivirus at different multiplicity of infection (MOI) value (10–80) and incubated for 12 h. Microglia were gathered 72 h after transfection, and transduction efficiency was measured with an inverted fluorescence microscopy (Olympus, Tokyo, Japan). Green signal represents infected cells. Transduction rate was approximately 90% at an MOI of 80. W: observation under white light; G: observation under green light.
![Figure 2. Transduction rate of lentiviral plasmid in microglia. Neonatal rat microglia were plated in six-well plates with complete medium 24 h prior infection. Next day, microglia were infected with IRE1 overexpressed lentivirus at different multiplicity of infection (MOI) value (10–80) and incubated for 12 h. Microglia were gathered 72 h after transfection, and transduction efficiency was measured with an inverted fluorescence microscopy (Olympus, Tokyo, Japan). Green signal represents infected cells. Transduction rate was approximately 90% at an MOI of 80. W: observation under white light; G: observation under green light.](/cms/asset/e6e6e8e2-caea-4a86-830c-40789effa06e/iphb_a_1991959_f0002_c.jpg)
Figure 3. ICA reduced the mRNA expression of IRE1α/XBP1 inflammatory signal axis induced by OGD/R. Microglia were subjected to 2 h of OGD followed by 24 h reoxygenation. ICA (0.37, 0.74 and 1.48 μmol/L) administration was performed 1 h prior OGD and maintained 2 h throughout OGD. IRE1α, XBP1u, XBP1s, NLRP3 and caspase-1 mRNA expression was assayed by qRT-PCR. Data are expressed as mean ± SD of three independent experiments. ##p< 0.01 vs. normal control group; *p< 0.05, **p< 0.01 vs. OGD/R group; ^^p< 0.01 vs. ICA-H group. ICA-L: 0.37 μmol/L ICA, ICA-M: 0.74 μmol/L ICA and ICA-H: 1.48 μmol/L ICA.
![Figure 3. ICA reduced the mRNA expression of IRE1α/XBP1 inflammatory signal axis induced by OGD/R. Microglia were subjected to 2 h of OGD followed by 24 h reoxygenation. ICA (0.37, 0.74 and 1.48 μmol/L) administration was performed 1 h prior OGD and maintained 2 h throughout OGD. IRE1α, XBP1u, XBP1s, NLRP3 and caspase-1 mRNA expression was assayed by qRT-PCR. Data are expressed as mean ± SD of three independent experiments. ##p< 0.01 vs. normal control group; *p< 0.05, **p< 0.01 vs. OGD/R group; ^^p< 0.01 vs. ICA-H group. ICA-L: 0.37 μmol/L ICA, ICA-M: 0.74 μmol/L ICA and ICA-H: 1.48 μmol/L ICA.](/cms/asset/a54ddb3f-cbf4-42a1-979a-ce6493f6be43/iphb_a_1991959_f0003_b.jpg)
Figure 4. ICA suppressed the protein expression of IRE1α/XBP1 inflammatory signal axis induced by OGD/R. Microglia were suffered from 2 h of OGD followed by 24 h reoxygenation. ICA (0.37, 0.74 and 1.48 μmol/L) administration was performed 1 h before OGD and acting through 2 h OGD. IRE1α, p-IRE1α, XBP1u, XBP1s, NLRP3 and caspase-1 protein expression was examined by WB. Data are expressed as mean ± SD of three independent experiments. ##p< 0.01 vs. normal control group; *p< 0.05, **p< 0.01 vs. OGD/R group; ^^p< 0.01 vs. ICA-H group. ICA-L: 0.37 μmol/L ICA, ICA-M: 0.74 μmol/L ICA and ICA-H: 1.48 μmol/L ICA.
![Figure 4. ICA suppressed the protein expression of IRE1α/XBP1 inflammatory signal axis induced by OGD/R. Microglia were suffered from 2 h of OGD followed by 24 h reoxygenation. ICA (0.37, 0.74 and 1.48 μmol/L) administration was performed 1 h before OGD and acting through 2 h OGD. IRE1α, p-IRE1α, XBP1u, XBP1s, NLRP3 and caspase-1 protein expression was examined by WB. Data are expressed as mean ± SD of three independent experiments. ##p< 0.01 vs. normal control group; *p< 0.05, **p< 0.01 vs. OGD/R group; ^^p< 0.01 vs. ICA-H group. ICA-L: 0.37 μmol/L ICA, ICA-M: 0.74 μmol/L ICA and ICA-H: 1.48 μmol/L ICA.](/cms/asset/cdf33a92-b0b9-4bc1-b0ec-4f1e4a172afa/iphb_a_1991959_f0004_b.jpg)
Figure 5. ICA inhibited the expression and release of IL-1β, IL-6 and TNF-α induced by OGD/R. Microglia were suffered to 2 h of OGD followed by 24 h reoxygenation. ICA administration was performed 1 h prior OGD and acting through 2 h OGD. IL-1β, IL-6 and TNF-α protein levels were measured by WB and ELISA. Data are expressed as mean ± SD of three independent experiments. ##p < 0.01 vs. normal control group. *p< 0.05, **p < 0.01 vs. OGD/R group. ^^p < 0.01 vs. ICA-H group. ICA-L: 0.37 μmol/L ICA, ICA-M: 0.74 μmol/L ICA and ICA-H: 1.48 μmol/L ICA.
![Figure 5. ICA inhibited the expression and release of IL-1β, IL-6 and TNF-α induced by OGD/R. Microglia were suffered to 2 h of OGD followed by 24 h reoxygenation. ICA administration was performed 1 h prior OGD and acting through 2 h OGD. IL-1β, IL-6 and TNF-α protein levels were measured by WB and ELISA. Data are expressed as mean ± SD of three independent experiments. ##p < 0.01 vs. normal control group. *p< 0.05, **p < 0.01 vs. OGD/R group. ^^p < 0.01 vs. ICA-H group. ICA-L: 0.37 μmol/L ICA, ICA-M: 0.74 μmol/L ICA and ICA-H: 1.48 μmol/L ICA.](/cms/asset/ee920836-d518-477a-806c-6de95fcd1f06/iphb_a_1991959_f0005_b.jpg)